2020 BioHealth Capital Region Forum

Top 3 by 2023

***PLEASE NOTE: the date of this forum has shifted to April 14-15th from April 15th-16th. We hope you still will be able to join us! ***

 

20% of the top influencers worldwide in vaccine development

 

World-class tech + big data + biotech + White House Precision Medicine Initiative = new frontiers in patient-centered medicine

1
1

MD | DC | VA

Our Goal: To become a Top 3 BioHealth Hub by 2023.

We are the research engine for the nation and the world. A lifeblood of support for taking new medicines to market. A place where health policymakers and patient advocates seek a better way forward. A home to the established and the startup, pioneering big ideas for human health and hope.

Driving Innovation and Entrepreneurship

  • World–renowned research institutions and universities
  • Influential policymakers and advocacy groups pioneering new health strategies
  • World–leading infectious disease research and vaccine development
  • Fastest growing region for healthcare companies in the U.S.
  • Rated #1 in the nation for science and engineering talent
  • Mission control for the National Cancer Moonshot Initiative

Founding Partners

BioBuzz: Hiring During a Biotech Boom: The Talent Challenges Facing Companies Across All Markets – Part 1

February 4, 2020

Part 1: This article is the first in a new series where we will explore the impact that the booming biotech market is having on hiring and talent strategies for…

BioBuzz: Vigene Biosciences Opens New Rockville Headquarters

February 3, 2020

Vigene Biosciences officially opened its new, state-of-the-art 51,000 square foot cell and gene therapy manufacturing facility in Rockville, Maryland at a ribbon-cutting ceremony on January 29th. The grand opening marked a…

So, You Want to Join a Life Science Startup?

January 21, 2020

Why You Should Consider Workplace Culture Before Taking the Leap The startup mythology has its origins in the tales of geniuses like Walt Disney, Bill Gates and Jeff Bezos’ going…

AMPEL BioSolutions Announces Gene-Based Lupus Diagnostic At Biotech Showcase In San Francisco

January 17, 2020

SAN FRANCISCO, Jan. 17, 2020 /PRNewswire/ — AMPEL BioSolutions’ Co-Founder and COO/CSO Dr. Amrie Grammer today at the Biotech Showcase at JP Morgan Healthcare announces the kickoff of a Series A $12.5M raise to commercialize LuGENETM, a…

Novavax Granted Fast Track Designation for NanoFlu in Older Adults

January 15, 2020

GAITHERSBURG, Md., Jan. 15, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast…

New Decade, Old Challenge: BioManufacturing Workforce Development Remains Key to Industry Growth

January 14, 2020

The BioHealth Capital Region (BHCR) experienced significant change in 2019 that has set the table for an intriguing 2020. How 2020 plays out across the region is unknown. However, if you’ve followed BioBuzz…